Crescent Biopharma (CBIO) Prepaid Assets (2013 - 2026)
Crescent Biopharma (CBIO) reported Prepaid Assets of $6.4 million for Q1 2026, up 2038.81% year-over-year from $299232.0 in Q1 2025, and up 17.15% quarter-over-quarter from $5.5 million in Q4 2025.
Crescent Biopharma (CBIO) Prepaid Assets (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of Prepaid Assets data on file, last reported at $6.4 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.4 million, up 2038.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 2038.81% YoY), and the FY2025 annual result was $5.5 million, up 14276.32% from the prior year.
- Prepaid Assets climbed to $6.4 million in Q1 2026 per CBIO's latest filing, from $5.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.4 million in Q1 2026 and troughed at $38000.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $1.3 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 98.1% in 2024, then jumped 14276.32% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $399861.0 in 2022, then jumped by 399.65% to $2.0 million in 2023, then tumbled by 98.1% to $38000.0 in 2024, then jumped by 14276.32% to $5.5 million in 2025, then rose by 17.15% to $6.4 million in 2026.
- Business Quant data shows CBIO's Prepaid Assets at $6.4 million in Q1 2026, $5.5 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 299,232.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 798,274.00 |
| Jun 30, 2024 | 589,133.00 |
| Mar 31, 2024 | 859,909.00 |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 399,861.00 |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 459,866.00 |
| Dec 31, 2021 | 273,396.00 |
| Sep 30, 2021 | 2.21 Mn |
| Jun 30, 2021 | 520,298.00 |